Back

Proteomics profiling reveals distinct molecular subtypes of hypertrophic cardiomyopathy with differential risks of major adverse cardiovascular events

28 August 2021 (12:30 - 12:45)
Organised by:
Congress Presentation Part of: Risk stratification in heart disease: the power of molecular tools Hypertrophic Cardiomyopathy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Lusha Liang

Columbia University Medical Centre, New York (United States of America)

2 More presentations in this session

Presentation thumbnail
State-of-the-art in risk stratification in heart disease: the power of molecular tools
Associate Professor J. Leopold (Boston, US)
Slides Video
Presentation thumbnail
Common genetic variants improve risk stratification after atrial switch operation for transposition of the great arteries
Ms O. Woudstra (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in heart disease: the power of molecular tools
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 12:30 CET